Open access · OA
via OpenAlex
Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies
Stefan Schildknecht, Hanne R. Gerding, Christiaan Karreman, Malte Drescher, Hilal Ahmed Lashuel, Tiago F. Outeiro, Donato A. Di Monte, Marcel Leist
Journal of Neurochemistry · 2013 · ▲ 148 citations
Abstract
Alpha-synuclein (ASYN) is a major constituent of the typical protein aggregates observed in several neurodegenerative diseases that are collectively referred to as synucleinopathies. A causal involvement of ASYN in the initiation and progression of neurological diseases is suggested by observations indicating that single-point (e.g., A30P, A53T) or multiplication mutations of the gene encoding for ASYN cause early onset forms of Parkinson's disease (PD). The relative regional specificity of ASYN pathology is still a riddle that cannot be simply explained by its expression pattern. Also, transgenic over-expression of ASYN in mice does not recapitulate the typical dopaminergic neuronal death observed in PD. Thus, additional factors must contribute to ASYN-related toxicity. For instance, synucleinopathies are usually associated with inflammation and elevated levels of oxidative stress in affected brain areas. In turn, these conditions favor oxidative modifications of ASYN. Among these modifications, nitration of tyrosine residues, formation of covalent ASYN dimers, as well as methionine sulfoxidations are prominent examples that are observed in post-mortem PD brain sections. Oxidative modifications can affect ASYN aggregation, as well as its binding to biological membranes. This would affect neurotransmitter recycling, mitochondrial function and dynamics (fission/fusion), ASYN's degradation within a cell and, possibly, the transfer of modified ASYN to adjacent cells. Here, we propose a model on how covalent modifications of ASYN link energy stress, altered proteostasis(definition), and oxidative stress, three major pathogenic processes involved in PD progression. Moreover, we hypothesize that ASYN may act physiologically as a catalytically regenerated scavenger of oxidants in healthy cells, thus performing an important protective role prior to the onset of disease or during aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/jnc.12226
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Schildknecht, S., Gerding, H.R., Karreman, C., Drescher, M., Lashuel, H.A., Outeiro, T.F., Monte, D.A.D., & Leist, M. (2013). Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. <em>Journal of Neurochemistry</em>. https://doi.org/10.1111/jnc.12226
Vancouver
Schildknecht S, Gerding HR, Karreman C, Drescher M, Lashuel HA, Outeiro TF, et al. Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. Journal of Neurochemistry. 2013. doi:10.1111/jnc.12226.
BibTeX
@article{stefan2013Oxidat,
title = {Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies},
author = {Stefan Schildknecht and Hanne R. Gerding and Christiaan Karreman and Malte Drescher and Hilal Ahmed Lashuel and Tiago F. Outeiro and Donato A. Di Monte and Marcel Leist},
journal = {Journal of Neurochemistry},
year = {2013},
doi = {10.1111/jnc.12226},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Experimental Gerontology 2001
Citation only
Oxidative stress and protein aggregation during biological aging
Frontiers in Cellular Neuroscience 2020
Open access · CC-BY
Cellular Senescence in Neurodegenerative Diseases
Frontiers in Cell and Developmental Biology 2021
Open access · CC-BY
PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
Journal of Alzheimer s Disease 2022
Open access · OA
Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay
Purdue e-Pubs (Purdue University System) 2010
Preprint
Role of alpha-synuclein primary structure and oxidative stress in Parkinson's disease pathology
biorxiv 2025
Preprint · CC-BY